Guidelines for biomarker-directed therapies in personalised medicine: Tools for assessment Timeline: Q2, 2019 – Q3, 2020 Issue:  Lack of guidance around the criteria that should be used to assess evidence for individualised/personalised clinical decisions especially linked to patient’s biomarker profile. Purpose:  Optimise treatments according to individualised patient characteristics and efficiencies. Objectives:  Development of the theoretical … Continue reading Project 5